• Significant progress made in the DEINOL programme with the launch of a series of trials in preindustrial fermenters (300L) in preparation and increased testing on commercial substrates.
  • Acceleration of green chemistry programmes with increased staffing and the prospect of significant partnerships in the near term.
  • Half-year net loss reduced by 8% (loss of 1.3 million Euros vs. a loss 1.4 million Euros in H1 2012).
  • Sufficient cash resources to cover the Company’s needs until Q3 2014, a significant improvement on guidance made earlier this year.


DEINOVE (Alternext Paris: ALDEI), a cleantech company that designs, develops and markets the next generation of industrial processes based on the Deinococcus bacteria, today announced its interim results for 2013.